Literature DB >> 2191882

Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?

C E Mogensen1.   

Abstract

This perspective deals with prediction of overt diabetic nephropathy in patients with insulin-dependent diabetes mellitus (IDDM). The role of elevated urinary albumin excretion rate (microalbuminuria) in predicting diabetic nephropathy has been emphasized by new follow-up studies. Development of severe kidney impairment was seen in a large percentage of patients with microalbuminuria, but with more intensive care for diabetic patients, this percentage may be falling. Herein, I analyzed alternatives to microalbuminuria in predicting kidney disease in diabetes. 1) Parental predisposition to hypertension is not seen in all studies and therefore may not be a decisive factor, and it cannot be used in prediction of nephropathy. 2) Prediabetic blood pressure may predict nephropathy in certain non-insulin-dependent diabetic patients, but elevated blood pressure seems to develop after early microalbuminuria and is likely to be an aggravating factor in established microalbuminuria in IDDM patients. 3) At the clinical diagnosis of IDDM, diabetic nephropathy cannot be predicted. 4) Glycemic control is poor in normoalbuminuric patients with later development of microalbuminuria, and multiple glycosylated hemoglobin measurements are therefore important. 5) In diabetes, glomerular hyperfiltration is associated with late nephropathy, but it alone cannot be the decisive factor, because hyperfiltration in nondiabetic individuals does not produce kidney disease, according to new long-term follow-up studies. 6) Studies of glomerular structure and ultrastructure have not yet documented predictive values for overt nephropathy, but further studies are in progress. 7) Isolated blood pressure elevation without microabuminuria (probably representing essential hypertension in diabetes) has not been predictive. 8) It is clear that elevation of serum creatinine is a very late and insensitive parameter, occurring only with pronounced proteinuria.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2191882     DOI: 10.2337/diab.39.7.761

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

1.  Diabetic nephropathy: evidence for renoprotection and practice.

Authors:  C E Mogensen
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

2.  Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus.

Authors:  L O Simpson
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

3.  Glomerular epithelial foot processes and filtration slits in IDDM patients.

Authors:  S F Bjørn; H J Bangstad; K F Hanssen; G Nyberg; J D Walker; G C Viberti; R Osterby
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

Review 4.  Treatment of the metabolic syndrome: the impact of lifestyle modification.

Authors:  Allison M Pritchett; John P Foreyt; Douglas L Mann
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

5.  Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.

Authors:  K Arakawa; T Ishihara; A Oku; M Nawano; K Ueta; K Kitamura; M Matsumoto; A Saito
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  Association between obesity and glomerular hyperfiltration: the confounding effect of smoking and sodium and protein intakes.

Authors:  Adam Ogna; Valentina Forni Ogna; Murielle Bochud; Idris Guessous; Fred Paccaud; Michel Burnier; Gregoire Wuerzner
Journal:  Eur J Nutr       Date:  2015-05-14       Impact factor: 5.614

7.  The effects of continuing and discontinuing smoking on the development of chronic kidney disease (CKD) in the healthy middle-aged working population in Japan.

Authors:  Yuka Noborisaka; Masao Ishizaki; Yuichi Yamada; Ryumon Honda; Hitoshi Yokoyama; Masaru Miyao; Masaji Tabata
Journal:  Environ Health Prev Med       Date:  2012-05-24       Impact factor: 3.674

Review 8.  C-peptide: a new potential in the treatment of diabetic nephropathy.

Authors:  J Wahren; K Ekberg; B Samnegård; B L Johansson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

9.  Long-term effects of linoleic-acid-enriched diet on albuminuria and lipid levels in type 1 (insulin-dependent) diabetic patients with elevated urinary albumin excretion.

Authors:  R P Dullaart; B J Beusekamp; S Meijer; K Hoogenberg; J J van Doormaal; W J Sluiter
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

10.  Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.

Authors:  P J Beisswenger; L L Moore; T Brinck-Johnsen; T J Curphey
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.